Real-Time Patient Recruitment Metrics for Clinical Trial Success

By BBK Worldwide on Thu, Mar 6, 2014

It’s a no brainer that applied metrics are invaluable for more accurately projecting patient recruitment; however, many people assume that once a trial is underway, it’s no longer necessary to measure anything until all the study data are accumulated. That’s just not true. There is tremendous value  in the ongoing application of metrics, throughout the entire study cycle, so much so that we sometimes find it hard to imagine how anyone can conduct a successful study without metrics. But we’re not talking about numbers for numbers’ sake. It takes a great deal of expertise to know which measurements to take and how to interpret the findings.

Topics: TrialCentralNet, Metrics and Reporting

Five Facets of Good Site Enrollment Support for Clinical Trials

By BBK Worldwide on Fri, Feb 21, 2014

Years ago sponsors generally believed that site enrollment support simply involved developing generic outreach materials, mailing them out to each site and perhaps holding a brief training session on how to use the materials. It’s no wonder most studies failed to enroll on time. Today, most patient enrollment specialists, including BBK, define site enrollment support in terms of five broad areas of action.

Topics: Patient Retention, Patient Recruitment

BBK’s Patient Recruitment Gift Guide

By BBK Worldwide on Fri, Dec 13, 2013

This season, give the gift of on-time enrollment with our holiday gift guide. From cutting-edge technologies to traditional patient recruitment tactics, we have something for everyone on your list!

Topics: BBK Worldwide

PharmaLive Interview with Matt Kibby on Study eBinder 3.0

By BBK Worldwide on Fri, Dec 6, 2013

Our colleagues at PharmaLive interviewed Matt Kibby, principal, technology and innovation, about the release of Study eBinder 3.0, the latest generation of our clinical trial management tool for on-the-go study teams. Click here to access the interview, or read below…  

Topics: Patient Retention, Patient Recruitment, Disruptive Innovation, Technology

BBK Worldwide Announces Study eBinder Clinical Trial Management Tool

By BBK Worldwide on Fri, Nov 22, 2013

Customized Apple® iPad AirTM Enhances Doctor-Patient Interactions in Clinical Trials

Topics: mHealth, Physician Engagement, Mobile Strategies, Technology

Matthew Stumm Named One of the Most Inspiring Individuals in the Life-Sciences Industry by PharmaVOICE

By BBK Worldwide on Wed, Aug 21, 2013

Matthew Stumm, principal, BBK Worldwide (BBK), has been named by PharmaVOICE magazine as one of the 100 most inspiring individuals throughout the life-sciences industry. Recognized as a leading “change agent,” Stumm is credited with revolutionizing traditional patient recruitment tactics. Stumm has been instrumental in forging BBK’s milestones of innovation, including leveraging Google virtual tours for patient and site engagement. More recently, he led an industry-wide dialogue about mobile technologies and the role apps play in healthcare awareness.

Topics: BBK Worldwide, Awards, Branding and Advertising

BBK Worldwide Expands Mobile Strategy for Patient Recruitment to Include “In-App” Advertising

By BBK Worldwide on Tue, Apr 9, 2013

Agency Engages Untapped Audiences and Provides Clinical Trial Sponsors With Increased Return on Investment

Topics: Patient Retention, Patient Recruitment, Disruptive Innovation, Mobile Strategies, Technology

Research Talent For Successful Multinational Trials

By BBK Worldwide on Tue, Mar 26, 2013

Imagine doubling the size of a football field and the teams that play on it. Bigger territory and more players might require a reorganization of responsibilities on the field. Suddenly, it’s a new game. Players who once held supporting roles might find themselves in key positions accountable for scoring. But will their talents be a natural fit for the new job? Some will and some won’t. It makes sense. A similar scenario is playing out in the clinical research industry. The proliferation of multinational studies has broadened the clinical research playing field, bringing accountability for “scoring” up the chain. Country study managers (CSMs), responsible for the success of a protocol within their country, are now accountable for more complex and strategic activities, including patient enrollment — the clinical study equivalent to scoring.

Topics: BBK Worldwide, Patient Recruitment, Cultural Adaptation, Site Selection

Defying Industry Trends, BBK Worldwide Expands Ownership From Within

By BBK Worldwide on Fri, Mar 22, 2013

Global Patient Recruitment Leader Further Defines How Small Business Thrives in Mammoth Industry

In an industry increasingly defined by mergers and acquisitions, BBK Worldwide (BBK) is bucking the trend by creating ownership opportunities from within. Celebrating 30 years, BBK remains one of the only independent and self-funded patient recruitment agencies, and is able to offer its global pharmaceutical and medical device clients levels of flexibility and creative innovation unmatched by its competitors. This history of vision and leadership has led BBK to name four additional principals who, together, will assume a minority ownership in the company. All long-serving employees, Matthew Kibby, Rob Laurens, Liz Ritchie, and Matthew Stumm have played key roles in shaping the company's success as the global leader in patient recruitment for the clinical R&D segment of the pharma, biotech, and medical device industries. As principals, they will partner with BBK's founding principals Joan F. Bachenheimer and Bonnie A. Brescia to maintain the company's core mission and values while driving growth in key market areas.

Topics: BBK Worldwide

Join us at the 5th Annual Patient Recruitment and Retention Summit!

By BBK Worldwide on Mon, Feb 11, 2013

Topics: BBK Worldwide, Patient Retention, Patient Recruitment, Conferences

Subscribe To Our Blog